Rimonabant induced anorexia in rodents is not mediated by vagal or sympathetic gut afferents

Andreas N. Madsen, Jacob Jelsing, Esther H E M van de Wall, Niels Vrang, Philip J. Larsen, Gary J. Schwartz

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

The selective CB1 receptor antagonist rimonabant is a novel weight control agent. Although CB1 receptors and binding sites are present in both the rodent central and peripheral nervous systems, including the afferent vagus nerve, the role of gut afferents in mediating anorexia following CB1R blockade is still debated. In the present study we examined rimonabant-induced anorexia in male C57BL/6J mice with subdiaphragmatic vagotomy (VGX) as well as in male Sprague-Dawley rats subjected to either subdiaphragmatic vagal deafferentation (SDA) alone or in combination with a complete celiac-superior mesenteric ganglionectomy (CGX). Irrespective of the operational procedure, rimonabant (10 mg/kg) effectively reduced standard chow as well as palatable diet (ensure) intake. In conclusion, the data clearly demonstrate that neither vagal gut afferents, nor gut afferents traveling via the sympathetic nervous system, are required for rimonabant to inhibit food intake leading to the hypothesis that centrally located CB1 receptors are the prime mediators of rimonabant-induced anorexia.

Original languageEnglish (US)
Pages (from-to)20-23
Number of pages4
JournalNeuroscience Letters
Volume449
Issue number1
DOIs
StatePublished - Jan 2 2009

Fingerprint

rimonabant
Anorexia
Rodentia
Cannabinoid Receptor CB1
Ganglionectomy
Vagus Nerve
Vagotomy
Sympathetic Nervous System
Peripheral Nervous System
Inbred C57BL Mouse
Abdomen
Sprague Dawley Rats
Central Nervous System
Eating
Binding Sites
Diet
Weights and Measures

Keywords

  • Food intake
  • Meal pattern
  • Obesity
  • Vagotomy
  • Visceral afferents

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Rimonabant induced anorexia in rodents is not mediated by vagal or sympathetic gut afferents. / Madsen, Andreas N.; Jelsing, Jacob; van de Wall, Esther H E M; Vrang, Niels; Larsen, Philip J.; Schwartz, Gary J.

In: Neuroscience Letters, Vol. 449, No. 1, 02.01.2009, p. 20-23.

Research output: Contribution to journalArticle

Madsen, Andreas N. ; Jelsing, Jacob ; van de Wall, Esther H E M ; Vrang, Niels ; Larsen, Philip J. ; Schwartz, Gary J. / Rimonabant induced anorexia in rodents is not mediated by vagal or sympathetic gut afferents. In: Neuroscience Letters. 2009 ; Vol. 449, No. 1. pp. 20-23.
@article{983c6963e58c4583962ab0eb4c3061fd,
title = "Rimonabant induced anorexia in rodents is not mediated by vagal or sympathetic gut afferents",
abstract = "The selective CB1 receptor antagonist rimonabant is a novel weight control agent. Although CB1 receptors and binding sites are present in both the rodent central and peripheral nervous systems, including the afferent vagus nerve, the role of gut afferents in mediating anorexia following CB1R blockade is still debated. In the present study we examined rimonabant-induced anorexia in male C57BL/6J mice with subdiaphragmatic vagotomy (VGX) as well as in male Sprague-Dawley rats subjected to either subdiaphragmatic vagal deafferentation (SDA) alone or in combination with a complete celiac-superior mesenteric ganglionectomy (CGX). Irrespective of the operational procedure, rimonabant (10 mg/kg) effectively reduced standard chow as well as palatable diet (ensure) intake. In conclusion, the data clearly demonstrate that neither vagal gut afferents, nor gut afferents traveling via the sympathetic nervous system, are required for rimonabant to inhibit food intake leading to the hypothesis that centrally located CB1 receptors are the prime mediators of rimonabant-induced anorexia.",
keywords = "Food intake, Meal pattern, Obesity, Vagotomy, Visceral afferents",
author = "Madsen, {Andreas N.} and Jacob Jelsing and {van de Wall}, {Esther H E M} and Niels Vrang and Larsen, {Philip J.} and Schwartz, {Gary J.}",
year = "2009",
month = "1",
day = "2",
doi = "10.1016/j.neulet.2008.10.001",
language = "English (US)",
volume = "449",
pages = "20--23",
journal = "Neuroscience Letters",
issn = "0304-3940",
publisher = "Elsevier Ireland Ltd",
number = "1",

}

TY - JOUR

T1 - Rimonabant induced anorexia in rodents is not mediated by vagal or sympathetic gut afferents

AU - Madsen, Andreas N.

AU - Jelsing, Jacob

AU - van de Wall, Esther H E M

AU - Vrang, Niels

AU - Larsen, Philip J.

AU - Schwartz, Gary J.

PY - 2009/1/2

Y1 - 2009/1/2

N2 - The selective CB1 receptor antagonist rimonabant is a novel weight control agent. Although CB1 receptors and binding sites are present in both the rodent central and peripheral nervous systems, including the afferent vagus nerve, the role of gut afferents in mediating anorexia following CB1R blockade is still debated. In the present study we examined rimonabant-induced anorexia in male C57BL/6J mice with subdiaphragmatic vagotomy (VGX) as well as in male Sprague-Dawley rats subjected to either subdiaphragmatic vagal deafferentation (SDA) alone or in combination with a complete celiac-superior mesenteric ganglionectomy (CGX). Irrespective of the operational procedure, rimonabant (10 mg/kg) effectively reduced standard chow as well as palatable diet (ensure) intake. In conclusion, the data clearly demonstrate that neither vagal gut afferents, nor gut afferents traveling via the sympathetic nervous system, are required for rimonabant to inhibit food intake leading to the hypothesis that centrally located CB1 receptors are the prime mediators of rimonabant-induced anorexia.

AB - The selective CB1 receptor antagonist rimonabant is a novel weight control agent. Although CB1 receptors and binding sites are present in both the rodent central and peripheral nervous systems, including the afferent vagus nerve, the role of gut afferents in mediating anorexia following CB1R blockade is still debated. In the present study we examined rimonabant-induced anorexia in male C57BL/6J mice with subdiaphragmatic vagotomy (VGX) as well as in male Sprague-Dawley rats subjected to either subdiaphragmatic vagal deafferentation (SDA) alone or in combination with a complete celiac-superior mesenteric ganglionectomy (CGX). Irrespective of the operational procedure, rimonabant (10 mg/kg) effectively reduced standard chow as well as palatable diet (ensure) intake. In conclusion, the data clearly demonstrate that neither vagal gut afferents, nor gut afferents traveling via the sympathetic nervous system, are required for rimonabant to inhibit food intake leading to the hypothesis that centrally located CB1 receptors are the prime mediators of rimonabant-induced anorexia.

KW - Food intake

KW - Meal pattern

KW - Obesity

KW - Vagotomy

KW - Visceral afferents

UR - http://www.scopus.com/inward/record.url?scp=56749150743&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=56749150743&partnerID=8YFLogxK

U2 - 10.1016/j.neulet.2008.10.001

DO - 10.1016/j.neulet.2008.10.001

M3 - Article

C2 - 18926875

AN - SCOPUS:56749150743

VL - 449

SP - 20

EP - 23

JO - Neuroscience Letters

JF - Neuroscience Letters

SN - 0304-3940

IS - 1

ER -